Amgen Inc. sell Bank of America Co.
Start price
26.09.25
/
50%
€231.00
Target price
26.09.26
€233.10
Performance (%)
22.37%
Price
09.01.26
€280.30
Summary
This prediction is currently active. The prediction currently has a disappointing performance of 22.37%. Dividends of €2.38 are taken into consideration when calculating the performance. This prediction currently runs until 26.09.26. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amgen Inc. | 0.215% | 0.215% |
| iShares Core DAX® | 3.002% | 4.755% |
| iShares Nasdaq 100 | 2.966% | 0.363% |
| iShares Nikkei 225® | 5.606% | 4.528% |
| iShares S&P 500 | 2.312% | 1.811% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Amgen Inc. diskutieren
Amgen (NASDAQ:AMGN) had its price target raised by analysts at Bank of America Corporation from $261.00 to $272.00. They now have an "underperform" rating on the stock.
Ratings data for AMGN provided by MarketBeat